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Resident tissue macrophages are activated by the fungal
pathogen Candida albicans to release eicosanoids, which are
important modulators of inflammation and immune responses.
Our objective was to identify the macrophage receptors engaged
by C. albicans that mediate activation of group IVA cytosolic
phospholipase A2 (cPLA2␣), a regulatory enzyme that releases
arachidonic acid (AA) for production of prostaglandins and leukotrienes. A comparison of peritoneal macrophages from wild
type and knock-out mice demonstrates that the ␤-glucan receptor Dectin-1 and MyD88 regulate early release of AA and eicosanoids in response to C. albicans. However, cyclooxygenase 2
(COX2) expression and later phase eicosanoid production are
defective in MyD88ⴚ/ⴚ but not Dectin-1ⴚ/ⴚ macrophages. Furthermore, C. albicans-stimulated activation of MAPK and
phosphorylation of cPLA2␣ on Ser-505 are regulated by MyD88
and not Dectin-1. In contrast, Dectin-1 mediates MAPK activation,
cPLA2␣ phosphorylation, and COX2 expression in response to
particulate ␤-glucan suggesting that other receptors engaged by C.
albicans preferentially mediate these responses. Results also implicate the mannan-binding receptor Dectin-2 in regulating cPLA2␣.
C. albicans-stimulated MAPK activation and AA release are
blocked by D-mannose and Dectin-2-specific antibody, and overexpression of Dectin-2 in RAW264.7 macrophages enhances C. albicans-stimulated MAPK activation, AA release, and COX2 expression. In addition, calcium mobilization is enhanced in RAW264.7
macrophages overexpressing Dectin-1 or -2. The results demonstrate that C. albicans engages both ␤-glucan and mannan-binding
receptors on macrophages that act with MyD88 to regulate the
activation of cPLA2␣ and eicosanoid production.
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The innate immune system is an important first line of
defense against invasive pathogens (1). Myeloid cells, including
mononuclear phagocytes and granulocytes, that first encounter
microorganisms initiate innate immune responses to contain
infections. Professional phagocytes possess a number of receptors, such as Toll-like receptors and C-type lectin receptors,
which recognize specific molecular components on microorganisms (2– 4). Engagement of these receptors initiates signaling pathways that trigger the production of chemokines
and cytokines that are important for recruiting other myeloid cells to the site of infection and for initiating adaptive
immunity (5, 6).
Candida albicans is a human commensal that colonizes the
gastrointestinal tract, skin, and mucosal surfaces. It is an opportunistic fungal pathogen in immunocompromised hosts and
the critically ill, and is the principal cause of mycoses worldwide
(7). C. albicans is responsible for a large proportion of nosocomial bloodstream infections with a crude mortality rate of over
40% (7). It invades through injuries in the skin or mucosa and
can colonize most tissues particularly the gastrointestinal tract,
lung, kidney, and brain. Toll-like receptors and C-type lectin
receptors have been identified on macrophages that recognize
cell wall components of C. albicans (8 –10). The cell wall of C.
albicans is composed of polysaccharides of glucose (␤-1,3- and
-1,6-glucans), N-acetyl-D-glucosamine (chitin), and mannose
(mannans) (11–14). TLR4, the C-type lectin receptors Dectin-2
and Mincle, and the macrophage mannose receptor have
been implicated in the recognition of C. albicans mannans
(8, 10, 15–17). A number of receptors have been reported to
bind to ␤-glucan, including Dectin-1, lactosylceramide,
complement receptor 3, and scavenger receptors (18 –21).
However, there is considerable evidence implicating the
phagocytic receptor Dectin-1 in mediating macrophage
responses to fungal agents and in regulating immune defense
to fungal infection in mice and humans (22–30). Dectin-1
contains a C-type lectin-like extracellular domain and an
immunoreceptor tyrosine-based activation-like motif in the
cytoplasmic tail that signals through spleen tyrosine kinase
(Syk) and CARD-9 (26, 31).
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We previously reported that C. albicans activates group IVA
cytosolic phospholipase A2 (cPLA2␣)3 in resident mouse peritoneal and alveolar macrophages (32, 33). cPLA2␣ releases
arachidonic acid (AA) that is metabolized to a number of bioactive lipid mediators such as prostaglandins and leukotrienes.
Eicosanoids are secreted by cells and regulate acute inflammation and innate immune responses (34). They act locally in an
autocrine or paracrine manner by binding to specific G-protein-coupled receptors.
Considerable progress has been made in identifying the
receptors engaged by C. albicans and the signaling pathways
that promote cytokine production, but the regulation of
cPLA2␣ activation and lipid mediator production is poorly
understood. cPLA2␣ is regulated post-translationally by
increases in intracellular calcium and phosphorylation (35).
Calcium binds to the C2 domain of cPLA2␣ and promotes
translocation from the cytosol to intracellular membranes for
accessing phospholipid substrate (36 –38). Phosphorylation of
Ser-505 by MAPK enhances the hydrolytic activity of cPLA2␣
(39, 40). Our previous results implicated a ␤-glucan receptor in
mediating the activation of cPLA2␣ by live C. albicans in resident peritoneal macrophages (32). Results of this study suggest
a role for Dectin-1, -2, and MyD88-dependent pathways in regulating cPLA2␣ activation and the production of eicosanoids in
macrophages.

EXPERIMENTAL PROCEDURES
Materials—Zymosan was purchased from Sigma and boiled
in PBS three times before use. Particulate ␤-glucan was purified
from Saccharomyces cerevisiae and structurally characterized
by NMR (41). Endotoxin-free water-soluble glucan phosphate
(soluble glucan-P) was prepared from particulate ␤-glucan as
described previously (42). [5,6,8,9,11,12,14,15-3H]AA (specific
activity 100 Ci/mmol) was from PerkinElmer Life Sciences.
Fetal bovine serum (FBS) (Gemini Bio-Products) was heat-inactivated at 56 °C for 30 min before use. Dulbecco’s modified
Eagle’s medium (DMEM) was from Cambrex BioScience.
Human serum albumin was obtained from Intergen. MAPK
inhibitors U0126 and SB202190 were obtained from Calbiochem. Polyclonal antibodies to murine COX2 and ␤-tubulin
were from Cayman Chemical Co. Polyclonal antibody to
cPLA2␣ was raised as described previously (43). Antibodies to
phosphorylated ERKs, p38, and cPLA2␣ (Ser-505) were
obtained from Cell Signaling Technology, Inc. Anti-Dectin-2
monoclonal antibody D2.11E4 was generated as described previously (15), and isotype control rat-IgG2a was obtained from
BioLegend. Fluo-4-AM was from Invitrogen. Zeocin was purchased from InvivoGen and G418 from Mediatech, Inc.
Mouse Strains—Pathogen-free BALB/c mice were obtained
from Harlan Sprague-Dawley. cPLA2␣⫺/⫺ mice were generated using 129 embryonic stem cells in a C57BL/6 strain as
described previously (44). The mixed strain was backcrossed
onto a BALB/c background and used after 10 generations. The
3

The abbreviations used are: cPLA2␣, cytosolic phospholipase A2; AA, arachidonic acid; m.o.i., multiplicity of infection; P-␤G, particulate-␤-glucan; RT,
retention time; PG, prostaglandin; LT, leukotriene; HETE, hydroxyeicosatetraenoic acid.
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TLR4 mutant mouse strain C3H/HeJ and control strain C3H/
HeOuJ were obtained from The Jackson Laboratory. TLR2⫺/⫺
(C57BL/6) and MyD88⫺/⫺ mice (C57BL/6/129) were generated as described previously (45). MyD88⫹/⫺ C57BL/6/129
mice were crossed to generate MyD88⫺/⫺ mice and MyD88⫹/⫹
littermate controls. C57BL/6 control mice were obtained from
The Jackson Laboratory. TLR9-deficient mice (BALB/c) were
provided by Dr. Ted Standiford (University of Michigan). Dectin-1⫺/⫺ mice (129sv/ev) were produced as described previously (28), and age- and strain-matched controls were obtained
from Taconic Farms, Inc. Mice were used for macrophage isolation at 7–12 weeks of age.
C. albicans Strains and Culture—C. albicans (ATCC 10261)
was grown on Sabouraud dextrose agar plates and maintained
at 4 °C. The day before the experiment, it was streaked onto a
fresh plate and incubated overnight at 37 °C. C. albicans was
scraped from the plate and washed twice in endotoxin-free PBS.
Peritoneal Macrophage Isolation and AA Release Assay—
Resident mouse peritoneal macrophages were obtained by peritoneal lavage as described previously (32). Cells were plated at a
density of 5 ⫻ 105/cm2 (48-well plate) and incubated for 2 h at
37 °C in a humidified atmosphere of 5% CO2 in air. After washing the cultures to remove nonadherent cells, the adherent
macrophages were incubated in DMEM containing 10% heatinactivated FBS, 100 g/ml streptomycin sulfate, 100 units/ml
penicillin G, 0.29 mg/ml glutamine, and [3H]AA (0.1 Ci/250
l/well) for 16 –18 h at 37 °C. The cells were washed twice with
serum-free DMEM containing 0.1% human serum albumin
(stimulation medium) to remove unincorporated [3H]AA and
then incubated in stimulation medium. After stimulation of the
macrophages, the culture medium was removed and centrifuged, and the amount of radioactivity released into the
medium was measured by scintillation counting. The cell-associated radioactivity was measured following solubilization of
the monolayer with 0.1% Triton X-100. The amount of radioactivity released is expressed as percent of the total radioactivity
incorporated (cell-associated plus medium).
RAW264.7 Macrophages Stably Expressing Dectin-1 or -2—
Dectin-1 and -2 were cloned into pFBNeo (Stratagene) or
pMXs-IZ vectors, respectively (46). They were transfected into
the HEK293T-based Phoenix ecotropic packaging cells using
FuGENE 6, and retroviral supernatants were collected after
48 h to transduce RAW264.7 cells expressing previously either
pMXs-IZ or pFBNeo, respectively. RAW264.7 cells expressing
both empty vectors were also generated. Cells were selected and
maintained in 0.6 mg/ml geneticin (Sigma) and 0.4 mg/ml Zeocin (Invitrogen). For FACS analysis, RAW264.7 were cultured
in a 24-well plate at 5 ⫻ 104 cells per well. The next day, the
medium was removed, and cells were incubated in blocking
buffer (PBS containing 5% heat-inactivated rabbit serum, 0.5%
BSA, 5 mM EDTA, 2 mM NaN3) for 1 h at 4 °C. Cells were
incubated with a 1:50 dilution of Alexa647-labeled anti-Dectin-1 or isotype control (AbD Serotec) for 1 h at 4 °C, washed
three times with washing buffer (PBS containing 0.5% BSA, 5
mM EDTA, and 2 mM NaN3), and resuspended in 1% formaldehyde (in PBS). The anti-Dectin-2 antibody (clone
D2.11E4) or its IgG2a isotype control (OX11) was added at
10 g/ml and incubated for 1 h at 4 °C. After two washes, a
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phycoerythrin-conjugated anti-rat antibody (Jackson ImmunoResearch) was added for a further 1 h at 4 °C. After this
time, cells were treated as those incubated with directly
labeled antibodies. Data were acquired on a CyAn ADP analyzer (Beckman-Coulter) and analysis was performed using
Summit software (Beckman-Coulter).
For measuring AA release, RAW264.7 cells were plated at 7.5 ⫻
104/cm2 well (48-well plates) in RPMI 1640 medium containing
10% heat-inactivated FBS, 0.6 mg/ml G418, 0.4 mg/ml Zeocin, 100
g/ml streptomycin sulfate, 100 units/ml penicillin G, and 0.29
mg/ml glutamine. After ⬃6 h, they were washed once and incubated in RPMI containing [3H]AA, and release of AA was measured as described above for mouse peritoneal macrophages.
C. albicans Recognition Assay—Peritoneal macrophages cultured overnight as described above were incubated with C. albicans (m.o.i. 5) in stimulation medium for 1 h. Macrophages
were washed three times with PBS and then lysed with 0.1%
Triton X-100 in PBS. C. albicans in the lysate was plated on
Sabouraud dextrose agar plates. The number of colony-forming units was determined after incubation of plates for 24 h at
37 °C. The phagocytic index was determined by using microscopy to quantify C. albicans phagocytosis by macrophages as
described previously (47).
Mass Spectrometry Eicosanoid Analysis—The culture medium was collected 1 and 6 h after macrophage stimulation,
centrifuged, and then stored at ⫺80 °C. The media were thawed
and mixed with an equal volume of cold methanol prior to
analysis. The samples were diluted in water to a final methanol
concentration of ⬍15% and then extracted using a solid phase
extraction cartridge (Strata Polymeric Reversed Phase 60
mg/ml, Phenomenex, Torrance, CA). The eluate (1 ml of methanol) was dried and reconstituted in 75 l of HPLC solvent A
(8.3 mM acetic acid and buffered to pH 5.7 with NH4OH) and 25
l of solvent B (acetonitrile/methanol, 65:35, v/v). An aliquot of
each sample (50 l) was injected into an HPLC, and metabolites
were separated on a C18 column (Ascentis 15 cm ⫻ 2.1 mm, 5
m, Supelco), eluted at a flow rate of 200 l/min with a linear
gradient from 25 to 75% solvent B in 13 min, and then increased
to 98% in 2 min and held for 11 min. The HPLC system was
directly interfaced into the electrospray ionization source of
a triple quadrupole mass spectrometer (Sciex API 3000, PESciex, Thornhill Ontario, Canada). Mass spectrometric analyses were performed in the negative ion mode using multiple
reaction monitoring for specific analytes. Deuterated internal
standards were detected using the following transitions: m/z
3553275 for d4-prostaglandin (PG) E2; m/z 3733173 for
d4-thromboxane B2; m/z 3733167 for d4-6-keto-PGF1␣; m/z
3113213 for d8-AA; m/z 6293272 for d4-LTC4; and m/z
3273116 for d8-5-HETE. Eicosanoids were detected centered
in specific retention time (RT) windows using the following
transitions and limits of quantitation: PGE2, RT 9.3 min, m/z
3513271, 8 pg/ml; thromboxane B2, RT 8.3 min, m/z
3693169, 40 pg/ml; AA, RT 20.5 min, m/z 3033259, 24 pg/ml;
6-keto-PGF1␣, RT 6.4 min, m/z 3693163, 40 pg/ml; LTC4, RT
10.1 min, m/z 6243272, 40 pg/ml; 5-HETE, RT 17.2 min, m/z
3193115, 8 pg/ml; 15-HETE, RT 16.5 min, m/z 3193219, 8
pg/ml. Multiple reaction monitoring chromatograms using a
similar analytic scheme have been described previously (48).
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Quantitative results were calculated by determining the ratio of
the signal of an analyte to that for an internal standard and
comparing with a standard isotope dilution curve (49).
Western Blots—To prepare lysates for Western blots, cell
monolayers were washed twice in ice-cold PBS and then
scraped in lysis buffer: 50 mM Hepes, pH 7.4, 150 mM sodium
chloride, 10% glycerol, 1% Triton X-100, 1 mM EGTA, 1 mM
EDTA, 200 M sodium vanadate, 10 mM tetrasodium pyrophosphate, 100 mM sodium fluoride, 300 nM p-nitrophenyl
phosphate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, and 10 g/ml aprotinin. After incubation on ice for 30
min, lysates were centrifuged at 15,000 rpm for 15 min, and
protein concentration in the supernatant was determined by
the bicinchoninic acid method. Lysates were boiled for 5 min
after addition of Laemmli electrophoresis sample buffer, and
proteins were then separated on 10% SDS-polyacrylamide gels.
After transfer to nitrocellulose membrane, samples were incubated in blocking buffer (20 mM Tris-HCl, pH 7.6, 137 mM
NaCl, 0.05% Tween (TTBS)) containing 5% nonfat milk for 1 h,
and then incubated overnight at 4 °C with primary antibodies in
TTBS. The membranes were incubated with anti-rabbit IgG
horseradish peroxidase antibody (1:5000) in TTBS for 30 min at
room temperature. The immunoreactive proteins were detected using the ECL system from Amersham Biosciences.
Calcium Imaging—RAW264.7 cells expressing Dectin-1 or
-2 and vector control cells were cultured overnight in glassbottomed MatTek plates in supplemented RPMI 1640 medium.
Cells were washed with Hanks’ balanced salt solution containing
25 mM Hepes, pH 7.4, and incubated with 5 M Fluo-4-AM in the
presence of 0.02% pluronic acid for 45 min at 25 °C. After loading,
the cells were washed with and incubated in phenol red-free
DMEM containing 25 mM Hepes, pH 7.4, for 30 min. Microscopy
was conducted on an inverted Zeiss 200 M microscope driven by
Intelligent Imaging Innovations Inc. software (Slidebook 4.2).
Images were collected every 5 s after adding zymosan. Fluorescent
traces of individual cells represent the fold fluorescence over base
line at time 0 (FT/F0) after background subtraction.
Statistics—Statistics were calculated in GraphPad using
unpaired t test to obtain two-tailed p values.

RESULTS
Role of Dectin-1 in Regulating AA Release and Eicosanoid
Production—We reported that C. albicans-stimulated AA
release is blocked by soluble glucan-P implicating a ␤-glucan
receptor (32). To determine whether Dectin-1 is the ␤-glucan
receptor that mediates cPLA2␣ activation and eicosanoid production in resident peritoneal macrophages in response to live
C. albicans, we compared Dectin-1⫹/⫹ and Dectin-1⫺/⫺
macrophages (Fig. 1). Dectin-1⫺/⫺ macrophages release ⬃55–
62% less AA in response to C. albicans (m.o.i. 2–5) than wild
type macrophages. Similar results are obtained with zymosan
(data not shown). In contrast, AA release is identical in Dectin1⫹/⫹ and Dectin-1⫺/⫺ macrophages stimulated with ionomycin, which activates cPLA2␣ in a receptor-independent manner
by increasing intracellular calcium. Purified particulate ␤-glucan stimulates AA release from Dectin-1⫹/⫹ macrophages but
not from Dectin-1⫺/⫺ macrophages indicating that it acts specifically through Dectin-1 (Fig. 1B).
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Resident peritoneal macrophages stimulated with C. albicans for 3 and 6 h produce PGE2, PGI2 (measured as the stable
metabolite 6-keto-PGF1␣), and LTC4 as the major oxygenated
metabolites of AA from the cyclooxygenase and lipoxygenase
pathways, and lower levels of thromboxane B2, 5-HETE, and
15-HETE (Table 1). Their levels are reduced to base line in
cPLA2␣⫺/⫺ macrophages (or were below the level of detection)
confirming an essential role for cPLA2␣. The role of Dectin-1 in
mediating eicosanoid production at early (1 h) and later (6 h)
times after adding C. albicans was determined. Levels of PGE2,
6-keto-PGF1␣, and LTC4 1 h after C. albicans (m.o.i. 5) addition
are ⬃65% lower in Dectin-1⫺/⫺ macrophages (Fig. 2) but by 6 h
levels are similar in Dectin-1⫺/⫺ and Dectin-1⫹/⫹ macrophages (Fig. 2). For determining the levels of eicosanoids produced 6 h after stimulation, lower amounts of C. albicans (m.o.i.
2) are initially added to avoid overgrowth of the yeast in the
culture medium. In contrast to C. albicans, particulate ␤-glucan-stimulated eicosanoid production is dependent on Dectin-1 at both 1 and 6 h (Fig. 2). When normalized to the amount
of eicosanoids produced by wild type macrophages, Dectin1⫺/⫺ macrophages produce significantly less eicosanoids when
stimulated with C. albicans for 1 h, but not at 6 h, and signifi-

FIGURE 1. Role of Dectin-1 in regulating AA release in peritoneal macrophages treated with C. albicans. [3H]AA-labeled wild type and Dectin-1⫺/⫺
macrophages were stimulated with C. albicans (ATCC 10261, serotype A), 1
M ionomycin (IONO) (A) or 100 g/ml particulate ␤-glucan (P-␤G) (B). The
amount of [3H]AA released into the medium from stimulated and unstimulated (US) cells is expressed as a % of the total incorporated radioactivity (cells
plus medium). The data are the average of three experiments ⫾S.E. The asterisk indicates a significant decrease (p ⬍ 0.05) for Dectin-1⫺/⫺ macrophages
compared with wild type macrophages.

cantly less with particulate ␤-glucan at both 1 and 6 h
(supplemental Table 1). C. albicans and particulate ␤-glucan
stimulate expression of COX2 in peritoneal macrophages that
occurs maximally by 6 h (32). COX2 expression is completely
attenuated in Dectin-1⫺/⫺ macrophages stimulated with particulate ␤-glucan but is not significantly decreased in Dectin1⫺/⫺ macrophages treated with C. albicans (Fig. 3). Levels of
total cPLA2␣ are similar in unstimulated Dectin-1⫹/⫹ and Dectin-1⫺/⫺ macrophages and are not affected by infection with C.
albicans for 6 h.
MyD88 Contributes to cPLA2␣ Activation and Eicosanoid
Production—The results above demonstrate that particulate
␤-glucan acts through Dectin-1 to activate cPLA2␣, COX2
expression, and eicosanoid production. However, in C. albicans-stimulated macrophages, Dectin-1 contributes to the
early activation of cPLA2␣, but other receptors promote COX2
expression and delayed phase eicosanoid production. We previously reported that TLR2 and TLR4, which are implicated in
mediating fungal responses, do not play a role in regulating
short term AA release in resident peritoneal macrophages stimulated with zymosan and C. albicans, but TLR2 partially mediates up-regulation of COX2 and prostanoid production (32).
We investigated the role of MyD88, the adaptor protein necessary for transducing signals of several other Toll-like receptors
and the interleukin-1 receptor (3). MyD88⫺/⫺ macrophages
stimulated for 1 h with C. albicans release ⬃50% less AA than
wild type cells (Fig. 4A). In contrast, wild type and MyD88⫺/⫺
macrophages release similar amounts of AA in response to particulate ␤-glucan. Eicosanoid production at 1 h after adding C.
albicans is also partially decreased in MyD88⫺/⫺ macrophages
(data not shown). The up-regulation of COX2 6 h after adding
C. albicans is almost completely ablated in MyD88⫺/⫺ peritoneal macrophages (Fig. 4B), and the production of PGE2, PGI2,
and LTC4 at 6 h is reduced by 80 –90% (Fig. 4C). In contrast
to Dectin-1⫺/⫺ macrophages, eicosanoid production in
MyD88⫺/⫺ macrophage stimulated with C. albicans for 6 h is
significantly lower than in wild type macrophages (supplemental Table 2). The results suggest a role for a receptor that
uses the MyD88 adaptor for signaling particularly for regulating
late phase eicosanoid production and COX2 expression.

TABLE 1
Levels of eicosanoids produced by wild type and cPLA2␣ⴚ/ⴚ peritoneal macrophages stimulated with C. albicans for 3 and 6 h
The lower limit of quantitation for the eicosanoids is specified under “Experimental Procedures.” The following abbreviations are used: US, unstimulated; TXB2, thromboxane B2; ND, not detected.
Time

Eicosanoid

cPLA2␣ⴙ/ⴙ
US

cPLA2␣ⴚ/ⴚ
C. albicans

US

ng/ml

C. albicans
ng/ml

3h

PGE2
6-Keto-PGF1␣
TXB2
LTC4
5-HETE
15-HETE

ND
ND
0.01 ⫾ 0.000
ND
0.02 ⫾ 0.000
0.03 ⫾ 0.015

2.44 ⫾ 0.834
1.90 ⫾ 0.618
0.11 ⫾ 0.022
3.33 ⫾ 0.237
0.26 ⫾ 0.022
0.19 ⫾ 0.042

ND
ND
ND
0.07 ⫾ 0.091
0.02 ⫾ 0.005
0.04 ⫾ 0.004

ND
ND
ND
0.01 ⫾ 0.004
0.02 ⫾ 0.000
0.04 ⫾ 0.009

6h

PGE2
6-Keto-PGF1␣
TXB2
LTC4
5-HETE
15-HETE

ND
ND
ND
0.01 ⫾ 0.004
0.02 ⫾ 0.004
0.06 ⫾ 0.003

3.07 ⫾ 0.208
2.90 ⫾ 0.337
0.16 ⫾ 0.002
5.74 ⫾ 0.497
0.30 ⫾ 0.043
0.26 ⫾ 0.004

ND
ND
ND
0.03 ⫾ 0.005
0.02 ⫾ 0.001
0.04 ⫾ 0.010

ND
ND
ND
0.02 ⫾ 0.007
0.02 ⫾ 0.010
0.05 ⫾ 0.002
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sures colony-forming units in the
macrophage cultures. The recognition of C. albicans is similar in wild
type and Dectin-1⫺/⫺ macrophages
implicating multiple receptors in
mediating C. albicans binding (Fig.
5C). The recognition of C. albicans
is partially blocked by D-mannose
(but not L-mannose), by a Dectin-2FIGURE 2. Role of Dectin-1 in mediating eicosanoid production in peritoneal macrophages. Wild type blocking antibody (but not by con(open bars) and Dectin-1⫺/⫺ (shaded bars) macrophages were incubated with live C. albicans for 1 (m.o.i. 5) or trol IgG), by mannans purified from
6 h (m.o.i. 2) or with 100 g/ml P-␤G. A lower m.o.i. of C. albicans is used for the longer time point to avoid
overgrowth in the culture medium. The culture medium was analyzed for eicosanoids by mass spectrometry. C. albicans, and by soluble glucan-P
The data are the average of three experiments ⫾ S.E. US, unstimulated; CA, C. albicans.
(Fig. 5C). Surprisingly, there was a
similar amount of blocking in wild
type and Dectin-1⫺/⫺ macrophages. The ability of soluble glucan-P to block recognition of C. albicans by macrophages lacking Dectin-1 suggests the presence of other receptors that contribute to ␤-glucan binding. These results were corroborated
using microscopy to determine the effect of the blocking agents
on phagocytosis of C. albicans. There was no significant differFIGURE 3. Role of Dectin-1 in COX2 induction. Expression of COX2 and total
⫺/⫺
cPLA2␣ in wild type and Dectin-1⫺/⫺ peritoneal macrophages was deter- ence in the phagocytic index of wild type and Dectin-1
mined by Western blotting. Cells were unstimulated (US) or stimulated with C. macrophages (data not shown). Treating the macrophages with
albicans (CA, m.o.i. 2) or 100 g/ml P-␤G for 6 h. Sample loading was determined using antibodies to ␤-actin. Results are representative of three inde- D-mannose, Candida mannans, the dectin-2-blocking antipendent experiments.
body, and soluble-glucan-P reduced the phagocytic index to a
similar extent (45–55%) in wild type and Dectin-1⫺/⫺ macroRole of a Mannan-binding Receptor—Blocking agents were phages (data not shown). The effect of soluble glucan-P and
used to investigate if a C. albicans mannan-binding receptor Candida mannans on C. albicans recognition by macrophages
regulates cPLA2␣ activation in peritoneal macrophages. Man- from BALB/c mice was also tested. Soluble glucan-P and mannans from C. albicans and D-mannose, but not L-mannose, nans reduce recognition (colony-forming units) to 58.0 ⫾ 5.6%
block C. albicans-stimulated AA release from peritoneal and 28.7 ⫾ 0.9% of levels observed in untreated macrophages
macrophages (BALB/c) (Fig. 5A). The release of AA stimulated (100%), respectively. When the peritoneal macrophages
by ionomycin is not blocked by D-mannose or C. albicans man- (BALB/c) are treated with both soluble glucan-P and Candida
nan (data not shown) suggesting that blocking is not due to a mannans, recognition is further reduced to 20.2 ⫾ 0.8% of connonspecific effect on activation of cPLA2␣. Resident peritoneal trols. Therefore, ␤-glucan and mannan-binding receptors conmacrophages poorly express the mannose receptor suggesting a tribute to C. albicans recognition in 129sv/ev and BALB/c
role for other mannan-binding receptors (50). The receptor macrophages.
Regulation of MAPK Activation and Phosphorylation of
galectin-3, which binds to C. albicans ␤-1,2-oligomannosides,
was ruled out because C. albicans-induced AA release is not cPLA2␣ on Ser-505—We investigated the role of Dectin-1 and
blocked by lactose, which prevents binding of C. albicans to MyD88 in regulating activation of MAPKs, which are imporgalectin-3 (51, 52).
tant in regulating cPLA2␣. We first confirmed that C. albicansDectin-2 is a mannan-binding C-type lectin expressed in stimulated AA release is blocked by 86% with the MEK1 inhibmyeloid cells that, together with Dectin-1, triggers cell activa- itor U0126 and 63% by the p38 inhibitor SB203560, similar to
tion through Syk and CARD 9 (16, 53). To investigate the role of previous results using zymosan (54). We compared the time
this mannan-binding receptor, the effect of Dectin-2-blocking course of ERK activation and phosphorylation of cPLA2␣ on
antibody on C. albicans-stimulated AA release from wild type Ser-505 in Dectin-1⫺/⫺ and wild type macrophages stimulated
and Dectin-1⫺/⫺ macrophages (129sv/ev) was determined. In with C. albicans and particulate ␤-glucan. Activation of ERKs in
wild type macrophages, Dectin-2 antibody blocked AA release response to C. albicans is evident by 15 min, peaks at 30 min,
as effectively as D-mannose and Candida mannans, but control and then remains activated at a lower level for 120 min (Fig. 6A).
antibodies had little effect (Fig. 5B). Dectin-2 antibodies further Surprisingly, the extent of ERK activation and phosphorylation
reduced AA release from Dectin-1⫺/⫺ macrophages, although of cPLA2␣ on Ser-505 is similar in Dectin-1⫺/⫺ and wild type
this did not reach statistical significance. Although control macrophages in response to C. albicans. In contrast, the activaantibodies had little effect on blocking AA release from C. albi- tion of ERKs and Ser-505 phosphorylation in macrophages
cans-stimulated Dectin-1⫹/⫹ macrophages, we consistently stimulated with particulate ␤-glucan is dependent on Dectin-1
observed that they enhanced AA release from C. albicans-stim- (Fig. 6A). In addition, the p38 MAPK is activated to a similar
extent by C. albicans in wild type and Dectin-1⫺/⫺ macroulated Dectin-1⫺/⫺ macrophages (Fig. 5B).
We also tested the effect of blocking agents on recognition phages (data not shown). We also compared the effect of ␤-glu(binding and internalization) of C. albicans by wild type and can and mannan-blocking agents on C. albicans-stimulated
Dectin-1⫺/⫺ macrophages (129sv/ev) using an assay that mea- ERK activation. C. albicans-stimulated ERK activation is
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cells correlates with a lower level of
phosphorylation of cPLA2␣ on Ser505. The results suggest that Dectin-2 and MyD88 pathways regulate
MAPK activation by C. albicans in
peritoneal macrophages.
Comparison of RAW264.7 Macrophages Expressing Dectin-1 and
-2—Our results suggest a role for
Dectin-1 and -2 in regulating C.
albicans-stimulated AA release in
peritoneal macrophages. The partial decrease in AA release observed
in Dectin-1⫺/⫺ macrophages is not
due to a defect in activation of
MAPKs and cPLA2␣ Ser-505 phosphorylation. Dectin-1 may regulate
cPLA2␣ by mediating calcium
mobilization. The ability of the Dectin-2 antibody to block ERK activation and AA release suggests a role
FIGURE 4. MyD88 regulates AA release, eicosanoid production, and COX2 expression. Wild type and for Dectin-2 in regulating cPLA2␣
MyD88⫺/⫺ peritoneal macrophages were stimulated with C. albicans (m.o.i. 5) and 100 g/ml P-␤G for 60 min activation in peritoneal macroto measure [3H]AA release (A), and with C. albicans (m.o.i. 2) for 6 h to evaluate COX2 expression on Western
blots using antibodies to total ERKs to evaluate sample loading (B), and to measure eicosanoids in the culture phages. Another approach to determedium by mass spectrometry (C). The data are the average of nine experiments for C. albicans and five mine whether Dectin-2 can proexperiments for P-␤G ⫾ S.E. (A), the average of three experiments ⫾ S.E. (C), and a representative of three mote AA release was to use
independent experiments (B). The asterisk in A indicates a significant decrease (p ⬍ 0.05) for MyD88⫺/⫺ macroRAW264.7 macrophages overexphages compared with wild type macrophages. US, unstimulated.
pressing Dectin-2. FACS analysis
confirmed the increased surface
expression of Dectin-1 and -2 in
RAW264.7 macrophages stably
expressing these receptors (supplemental Fig. 1). Vector controls
express a low level of Dectin-1 but
not Dectin-2. As shown in Fig. 7A,
C. albicans and particulate ␤-glucan
do not stimulate AA release from
FIGURE 5. Role of a C. albicans mannan-binding receptor. A, [3H]AA-labeled peritoneal macrophages RAW264.7 vector controls. Overex(BALB/c) were preincubated with D-mannose (DM), L-mannose (LM) (mM), or mannans from C. albicans (CM)
(mg/ml). B, [3H]AA-labeled peritoneal macrophages from wild type or Dectin-1⫺/⫺ mice were preincubated pressing Dectin-1 greatly increases
with D-mannose (100 mM), mannans from C. albicans (0.1 mg/ml), 10 g/ml Dectin-2-blocking antibody (D2 Ab) AA release in response to C. albior control antibody (Cont Ab). Macrophages were then stimulated with C. albicans (m.o.i. 5) for 60 min. The cans, as reported previously (32),
amount of [3H]AA release is expressed as a % of the total incorporated radioactivity (cells plus medium) after
subtracting background release. The blockers did not significantly affect background release. The asterisk and in response to particulate
indicates a significant decrease (p ⬍ 0.05) compared with untreated macrophages. C, macrophages were ␤-glucan. RAW264.7 cells overexincubated for 30 min with 100 mM D-mannose or L-mannose, 10 g/ml Dectin-2 antibody or control antibody,
100 g/ml soluble glucan-P (S-GP), and 100 g/ml mannans from C. albicans and then stimulated for 60 min pressing Dectin-2 also release sigwith C. albicans (m.o.i. 5). Macrophages were washed three times, and lysates were plated on Sabouraud agar nificantly higher levels of AA than
plates to determine colony-forming units (CFU). A representative of three independent experiments is shown. vector controls in response to C.
albicans but not to particulate
blocked almost completely by D-mannose in both wild type and ␤-glucan (Fig. 7A). Similar results are observed using zymosan
Dectin-1⫺/⫺ macrophages (Fig. 6B), but L-mannose has no (data not shown). In RAW264.7 cells overexpressing Dectin-1
effect (data not shown). The Dectin-2-blocking antibody, but or -2, there is an increase in ERK activation and COX2 expresnot control antibody, inhibits ERK activation in Dectin-1⫹/⫹ sion in response to C. albicans compared with vector controls
macrophages and to a slightly greater extent in Dectin-1⫺/⫺ (Fig. 7B). Particulate ␤-glucan increases these responses only in
macrophages. In contrast, soluble glucan-P weakly blocks ERK the Dectin-1-overexpressing cells. cPLA2␣ is expressed at simactivation in Dectin-1⫹/⫹ macrophages and has no effect on ilar levels in vector controls and RAW264.7 cells overexpressERK activation in Dectin-1⫺/⫺ macrophages (Fig. 6B). Activa- ing either Dectin-1 or -2 (Fig. 7B).
Live cell imaging of RAW264.7 cells loaded with Fluo-4 was
tion of ERKs and p38 in response to C. albicans is also partially
dependent on MyD88 (Fig. 6C). The reduced activation of these used to determine whether Dectin-1 and -2 mediate increases
kinases in MyD88⫺/⫺ macrophages compared with wild type in [Ca2⫹]i in response to zymosan. We used zymosan for these
OCTOBER 1, 2010 • VOLUME 285 • NUMBER 40
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expressing Dectin-2 also exhibit
increases in [Ca2⫹]i, although responses are generally lower than in
cells expressing Dectin-1. In contrast
to zymosan, ionomycin stimulates
increases in [Ca2⫹]i in vector controls
as well as in RAW264.7 cells expressing Dectin-1 and -2 (supplemental
Fig. 2).

DISCUSSION
This study demonstrates that C.
albicans stimulates cPLA2␣-depenFIGURE 6. Regulation of ERK activation and cPLA2␣ Ser-505 phosphorylation. Wild type (WT) and Dectin- dent production of AA metabolites
1⫺/⫺ (KO) macrophages were unstimulated (US) or stimulated with C. albicans (CA, m.o.i. 5) or 100 g/ml P-␤G from cyclooxygenase and lipoxygefor the indicated times (A) or treated with D-mannose (DM, 100 mM), 10 g/ml Dectin-2-blocking antibody (D2
Ab), control antibody (Cont Ab), or 100 g/ml soluble glucan-P (S-GP) and then stimulated with C. albicans nase pathways in resident perito(m.o.i. 5) for 30 min (B). C, wild type or MyD88 knock-out macrophages were treated with C. albicans (m.o.i. 5) for neal macrophages. The results show
30 min. Activation of ERKs (B, C) and cPLA2␣ Ser-505 (S505) (A, C) phosphorylation was determined on Western that recognition of C. albicans cell
blots using phospho-specific antibodies. Sample loading was evaluated using antibodies to total cPLA2␣ (A) or
wall components by peritoneal
␤-actin (B and C). A representative of three (A and B) or two (C) independent experiments is shown.
macrophages involves multiple
receptors that differentially regulate cPLA2␣-mediated AA release,
COX2 expression, and eicosanoid
production as summarized in Fig. 8.
Comparisons of wild type and
knock-out macrophages demonstrate that Dectin-1 and MyD88
contribute to cPLA2␣ activation
and eicosanoid production, and
blocking experiments suggest the
involvement of the mannan-binding receptor Dectin-2. In addition to
the recognition of fungal ␤-glucans
by Dectin-1, a number of mannosebinding C-type lectins such as
DC-SIGN (SIGNRs), Mincle, and
Dectin-2 contribute to fungal recognition and in some cases the
induction of responses in innate
immune cells (55–58).
FIGURE 7. Responses of RAW264.7 cells expressing Dectin-1 and Dectin-2. Vector control cells and
The results demonstrate that AA
RAW264.7 expressing Dectin-1 or -2 were stimulated with C. albicans (m.o.i. 5) or particulate ␤-glucan for 60
3
release
and production of eicomin to measure [ H]AA release (A) or for 30 min to measure ERK activation or 6 h to measure COX2 expression
on Western blots (B). Sample loading was evaluated using antibodies to total cPLA2␣ or ␤-actin. A, results are sanoids that occur early after infecthe average of three experiments ⫾ S.E. The asterisk indicates a significant increase (p ⬍ 0.05) compared with tion with C. albicans are mediated
vector controls. B, representation of three independent experiments is shown. C, live cell calcium imaging of
RAW264.7 cells loaded with Fluo-4 was determined over time after addition of zymosan (10 particles/cell). Data in part by binding of ␤-glucan to
are presented (FT/F0) relative to time 0, and starting F0 for each cell is set at 1. Each colored tracing represents Dectin-1 (Fig. 8). Resident mouse
data from an individual cell, and analysis of 15 cells for each condition from a representative of three experiperitoneal macrophages are unique
ments is shown.
in their ability to rapidly produce
relatively large quantities of prosexperiments because it was previously used to define the mode tanoids within minutes of stimulation through the COX1 pathof calcium mobilization in resident mouse peritoneal macro- way (59, 60). However, the more delayed production of eicophages (47). Zymosan does not induce increases in [Ca2⫹]i in sanoids and COX2 expression is similar in wild type and
vector control cells (Fig. 7C). In RAW264.7 cells expressing Dec- Dectin-1⫺/⫺ macrophages. It has been reported that Dectin-1
tin-1, many cells exhibit increases in [Ca2⫹]i in response to zymo- induces signals for cytokine production primarily during the
san. The timing and pattern of calcium responses of single cells initial interaction with ␤-glucan at the cell surface, and ligand
(each depicted as a different colored line) in the population is very binding promotes internalization of Dectin-1 and degradation
heterogeneous and may reflect differences in the timing of zymo- in lysosomes (27, 46, 61). However, results using the Dectin-1
san particle interaction with the cell surface. RAW264.7 cells agonist particulate ␤-glucan revealed that Dectin-1 can pro-

30682 JOURNAL OF BIOLOGICAL CHEMISTRY

VOLUME 285 • NUMBER 40 • OCTOBER 1, 2010

cPLA2␣ Activation in Macrophages by Candida albicans

FIGURE 8. Summary of signaling pathways for cPLA2␣ activation and
eicosanoid production stimulated by engagement of C. albicans cell wall
components with receptors in resident peritoneal macrophages. Our
results suggest that ␤-glucans (green) and mannans (orange) of the C. albicans
cell wall engage Dectin-1 and -2 on mouse peritoneal macrophages to promote increases in [Ca2⫹]i and activation of MAPKs, respectively. MyD88,
through an as yet unidentified receptor, also contributes to the early activation of MAPKs and phosphorylation of cPLA2␣ on Ser-505. Calcium binds to
the N-terminal C2 domain on cPLA2␣ and promotes translocation of cPLA2␣
from the cytosol to intracellular membrane to access phospholipid substrate.
Phosphorylation on Ser-505 enhances the release of AA by increasing the
catalytic activity of cPLA2␣. Dectin-1, -2, and MyD88 contribute to the early
release of eicosanoids, but the MyD88 pathway is preferentially used to mediate COX2 expression and the late response of eicosanoid production in resident peritoneal macrophages.

mote COX2 expression in peritoneal macrophages, but in
response to C. albicans, other receptors that act in part through
MyD88 preferentially mediate COX2 expression and delayed
eicosanoid production (Fig. 8). We also observed a similar phenomenon in mouse alveolar macrophages (33). Dectin-1 mediates early release of AA from mouse alveolar macrophages
primed with GM-CSF, which increases expression of Dectin-1,
but does not mediate C. albicans-stimulated COX2 expression
or PGE2 production. However, Dectin-1 does contribute to
production of TNF␣ stimulated by C. albicans in GM-CSFprimed alveolar macrophages (33). We also observed that Dectin-1⫺/⫺ peritoneal macrophages produce less TNF␣ in
response to C. albicans than wild type macrophages (data not
shown). Consequently, there is not a generalized attenuation of
Dectin-1 signaling in peritoneal macrophages stimulated with
C. albicans but preferential use of alternative pathways for sustained cPLA2␣ activation and expression of COX2.
We also investigated the role of Dectin-1 in mediating C.
albicans-stimulated activation of MAPKs, which regulate
cPLA2␣ activation and release of AA as observed previously
using zymosan (54). Surprisingly, the activation of MAPKs and
phosphorylation of cPLA2␣ on Ser-505 in response to C. albicans is similar in wild type and Dectin-1⫺/⫺ peritoneal macrophages, despite results showing that Dectin-1 can mediate activation of ERKs in peritoneal macrophages when stimulated
with particulate ␤-glucan. Therefore, there is preferential use of
OCTOBER 1, 2010 • VOLUME 285 • NUMBER 40

alternative signaling pathways for activation of both early
responses such as MAPK activation and later responses such as
COX2 expression in peritoneal macrophages stimulated with
C. albicans (Fig. 8). In contrast to peritoneal macrophages, we
found that the activation of ERKs by C. albicans is mediated by
Dectin-1 in GM-CSF-primed alveolar macrophages and in
RAW264.7 cells overexpressing Dectin-1 (32, 33). Therefore,
the role for Dectin-1 in mediating macrophage responses is
context-dependent and may reflect differences in relative levels
of expression of pattern recognition receptors and signaling
responses. The early activation of cPLA2␣ by Dectin-1 in peritoneal macrophages stimulated with C. albicans or zymosan
may involve the ability of Dectin-1 to promote increases in
[Ca2⫹]i as shown using RAW264.7 macrophages overexpressing Dectin-1 (Fig. 8). We were unable to accurately quantify
differences in calcium mobilization by live cell imaging in wild
type and Dectin-1⫺/⫺ peritoneal macrophages due to the cellto-cell heterogeneity of calcium responses using the particulate
agonist, and because AA release is only partially reduced in
Dectin-1⫺/⫺ macrophages.
Our results demonstrate that MyD88 plays a role in regulating activation of MAPKs (ERKs and p38) and phosphorylation
of cPLA2␣ on Ser-505 that may be the basis for the partially
reduced AA release in MyD88⫺/⫺ macrophages early after
stimulation with C. albicans. MyD88 also regulates COX2
expression and production of eicosanoids in peritoneal macrophages measured 6 h after C. albicans infection (Fig. 8). TLR2
and TLR4 do not regulate C. albicans-stimulated activation of
ERKs (data not shown) or AA release, but TLR2 partially mediates COX2 expression and prostanoid production (32). Because
C. albicans DNA induces TLR9-dependent cytokine production, and TLR9 can mediate cPLA2␣ activation (62, 63), we
compared peritoneal macrophages from wild type and TLR9
knock-out mice but found no role for TLR9 in regulating AA
release, ERK activation, COX2 expression, or eicosanoid production in response to C. albicans (data not shown). Another
possibility is that C. albicans stimulates production of IL-1␣,
IL-1␤, or IL-18 that act in an autocrine manner through the
IL-1 receptor to regulate responses through MyD88.
Our results demonstrate that recognition of C. albicans by
peritoneal macrophages involves binding to cell wall mannans
and ␤-glucans because it is blocked by soluble glucan-P, mannose, Candida mannans, and a Dectin-2-specific monoclonal
antibody (Fig. 8). Both Dectin-1 and -2 have been reported to
mediate binding of zymosan to mouse dendritic cells (53). The
ability of Dectin-1⫺/⫺ macrophages to bind and internalize C.
albicans to a similar extent as wild type macrophages suggests
that other receptors may compensate in the absence of Dectin-1. C. albicans binding to Dectin-1⫺/⫺ macrophages is
blocked by mannose/mannans but also by soluble glucan-P
suggesting the presence of other ␤-glucan-binding proteins.
However, particulate ␤-glucan does not stimulate AA release in
Dectin-1⫺/⫺ macrophages suggesting that other ␤-glucanbinding proteins do not signal for cPLA2␣ activation. Despite
similar levels of C. albicans recognition in wild type and Dectin1⫺/⫺ macrophages, Dectin-1⫺/⫺ macrophages release significantly less AA than wild type macrophages supporting a role for
this ␤-glucan receptor in promoting signals for cPLA2␣ activaJOURNAL OF BIOLOGICAL CHEMISTRY
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tion. In addition, our data suggest that Dectin-2 may signal for
activation of cPLA2␣. It has been shown that Dectin-2 mediates
production of cysteinyl leukotrienes in dendritic cells stimulated with dust mites (64). Dectin-2, which is highly expressed
in tissue macrophages, recognizes high mannose structures
(16). The binding of zymosan, C. albicans, and other fungi to
Dectin-2 requires calcium and is blocked by mannose (16, 65).
We previously reported that chelating extracellular calcium
reduces the binding and uptake of zymosan by resident peritoneal macrophages consistent with a role for Dectin-2 (47). Dectin-2 transduces intracellular signals through association with
FcR␥ chain (65). A recent report found that both Dectin-1 and
-2 mediate the Syk-Card-9-dependent responses of dendritic
cells to fungi (53). Although we found that soluble glucan-P,
mannose, and Dectin-2 antibody block C. albicans recognition
to a similar extent, mannose and the Dectin-2 antibody preferentially block ERK activation suggesting that Dectin-2 can provide signals for cPLA2␣ activation (Fig. 8). A role for Dectin-2 in
mediating activation of MAPKs in dendritic cells has been
reported (53). The results suggest a role for Dectin-2 and a
MyD88-dependent pathway, and not Dectin-1, in promoting
ERK activation in C. albicans-stimulated resident peritoneal
macrophages (Fig. 8). Dectin-1 may signal for cPLA2␣ activation by promoting calcium mobilization as demonstrated using
RAW264.7 macrophages expressing Dectin-1. The ability of
Dectin-2 to provide signals for cPLA2␣ activation is also supported by results using RAW264.7 macrophages overexpressing Dectin-2, which exhibit enhanced calcium mobilization and
the release of AA in response to fungal agents.
In summary, our study demonstrates that fungal agents
engage multiple receptors on resident peritoneal macrophages
that differentially regulate signals for the activation of cPLA2␣
and the production of eicosanoids that are important modulators of inflammation.
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